Anwita Biosciences Inc.
PrivateLast Round
Series B
Jun 28, 2021
Est. Valuation
$50M
Total Funding Raised
$28.5M
Company Overview
Anwita Biosciences Inc. operates in Healthcare & Life Sciences and is based in Santa Clara, California. Its latest recorded funding round was a Series B round in June 2021.
Anwita Biosciences Inc. is a clinical-stage biotechnology company that develops next-generation cancer immunotherapies, including its lead candidate AWT020.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anwita Biosciences Inc. Comparables
Compare Anwita Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cugene Inc. | 83% | |
| Bright Peak Therapeutics | 81% | |
| CD (Suzhou) Biopharma Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Anwita Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 28, 2021 | ||||
| Series A | Jun 24, 2019 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 65% MoM, reaching 2.8K.
- Mar 3, 2026
Monthly visitors increased 33% MoM.
For institutional investors. Book with your work email.
Anwita Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anwita Biosciences Inc.'s valuation, stock price, and market status.
Is Anwita Biosciences Inc. a public or private company?
Anwita Biosciences Inc. is a private company.
What is the current stock price of Anwita Biosciences Inc.?
Anwita Biosciences Inc. is a private company, so its shares have no public market price. Caplight tracks Anwita Biosciences Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anwita Biosciences Inc. worth (valuation)?
Anwita Biosciences Inc.'s valuation is estimated at $50.0M based on funding round data.
Can I buy Anwita Biosciences Inc. stock?
Anwita Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anwita Biosciences Inc.'s last funding round?
Anwita Biosciences Inc.'s most recent funding round was Series B on June 28, 2021.
Who are the main investors in Anwita Biosciences Inc.?
Investor information for Anwita Biosciences Inc. is not publicly disclosed.
Will Anwita Biosciences Inc. IPO soon?
No public IPO plans have been announced for Anwita Biosciences Inc..
How can I track Anwita Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Anwita Biosciences Inc.'s shares on secondary markets.